Anemarrhena asphodeloides + phellodendron chinense
Anemarrhena asphodeloides + phellodendron chinense has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 24, 2024: “Synergistic anti-osteoporosis effects of Anemarrhena asphodeloides bunge-Phellodendron chinense C.K. Schneid herb pair via ferroptosis suppression in ovariectomized mice”.
1 paper studies it2 findingsUpdated
See all 1 papers on anemarrhena asphodeloides + phellodendron chinense
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 2 more
- Animals1
What did studies of anemarrhena asphodeloides + phellodendron chinense find?
2Studies of anemarrhena asphodeloides + phellodendron chinense measured 2 outcomes: NFATC1 and bone mineral density.
NFATC1
downin mice1
1 study
NFATC1
downin mice1
Anemarrhena asphodeloides + phellodendron chinense decreases NFATC1 in mice (ovariectomized mice; compared with either herb alone).
“The effects of AA/PC were better than AA or PC alone on inhibiting the bone resorption marker nuclear factor of activated T-cells 1.”
Animalsovariectomized mice; compared with either herb alonefemales
Frontiers in pharmacology
Bone mineral density
upin mice1
1 study
Bone mineral density
upin mice1
Anemarrhena asphodeloides + phellodendron chinense increases bone mineral density in mice (ovariectomized mice).
“Micron-scale computed tomography analysis showed that AA/PC increased bone mineral density in OVX mice.”
Animalsovariectomized micebonefemales
Frontiers in pharmacology